What is I3LUNG
I3LUNG is a European project funded under the framework of the Horizon Europe (HEurope) call “Ensuring access to innovative, sustainable and high-quality health care”. Our consortium gathers 16 partners with different expertise located worldwide, with the common goal of providing better assistance and individualize treatment for patients affected by metastatic lung cancer.
For Patients
In the video below the project explained by Anne-Marie Baird, President of Lung Cancer Europe (LuCE) (one of the partners of the I3LUNG).
“We are excited to start this project which is envisioned to both generate novel therapeutic guidelines for clinical practice in lung cancer and support the growth of digital diagnostic tools in the European industry. (I3LUNG Partners)„
Find out the most relevant news on the latest advancements in lung cancer!
News
September, 10 2025
Barcelona in early September gave us more than late summer sun, tapas, and strolls by the beach, it gave us […]
News
September, 9 2025
On the final day of #WCLC25, Arsela Prelaj represented #I3LUNG at the Scientific Plenary with her talk: “Data-Driven oncology: how […]
News
September, 6 2025
Today marked the first day of the International Association for the Study of Lung Cancer hashtag#WCLC25 in Barcelona — and […]